. 2016 Sep 23;6:34019. doi: 10.1038/srep34019

Table 1. Correlation between risk of death and proteasome expression.

Breast cancer
Category	# of groups	Hazard Ratio [95% Confidence Interval]	p-value
CP^high vs CP^low	2	1.30 [0.83–2.02]	0.245
CP^high vs CP^low	3	1.02 [0.78–1.33]	0.960
IP^high vs IP^low	2	0.53 [0.35–0.82]	0.003
IP^high vs IP^low	3	0.74 [0.56–0.97]	0.074
AML
Category	# of groups	Hazard Ratio [95% Confidence Interval]	p-value
CP^high vs CP^low	2	1.35 [0.91–1.99]	0.133
CP^high vs CP^low	3	1.28 [0.79–2.08]	0.404
IP^high vs IP^low	2	1.42 [0.96–2.11]	0.076
IP^high vs IP^low	3	1.54 [0.95–2.51]	0.099

Patients were divided into two or three equal groups based on CP or IP z-score. Patients with M3 AML (n = 16) were not included in the analysis because they were not treated with the same chemotherapy regimen as other AML patients. Cox proportional hazards models were used to estimate hazard ratios (high group/low group) and 95% confidence intervals. The log-rank test was used to calculate p-values.